Opus Genetics Slides Ahead of June Test
Opus Genetics Inc. shares eased late Monday morning, retracing some of Friday’s advance. Investors are watching for the gene-therapy company’s slot at the Jefferies Global Healthcare Conference this week. The stock, which trades on the Nasdaq, slipped 7 cents to $4.29, off 1.6%. Shares opened at $4.40 and ranged from $4.20 to $4.49. Volume was roughly 288,500 shares. Market cap sat near $373 million.
